hematoporphyrin has been researched along with Carcinoma, Non-Small Cell Lung in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Gao, Y; Li, X; Li, Z; Wang, J; Xu, L; Zhu, F | 1 |
| Guan, W; Li, ZP; Wang, D; Wang, G; Xia, L; Yang, ZZ; Zeng, LL; Zhang, YS | 1 |
| Dai, N; Li, MX; Li, ZP; Wang, D; Wang, G; Xiang, DB; Yang, ZZ; Zeng, LL; Zhang, YS | 1 |
| Bekaii-Saab, T; Grecula, J; Magro, C; Otterson, G; Ross, P; Villalona-Calero, M | 1 |
| Locicero, J | 1 |
| Baas, P; Stewart, F; Sutedja, T; van Zandwijk, N | 1 |
| Coy, EP; Kostashuk, EC; Lam, S; Laukkanen, E; LeRiche, JC; Mueller, HA; Szasz, IJ | 1 |
1 trial(s) available for hematoporphyrin and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
A randomized comparative study of the safety and efficacy of photodynamic therapy using Photofrin II combined with palliative radiotherapy versus palliative radiotherapy alone in patients with inoperable obstructive non-small cell bronchogenic carcinoma.
Topics: Aged; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Dihematoporphyrin Ether; Female; Hematoporphyrin Photoradiation; Hematoporphyrins; Humans; Lung Neoplasms; Male; Middle Aged; Palliative Care; Photochemotherapy; Random Allocation | 1987 |
6 other study(ies) available for hematoporphyrin and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Co-delivery of gefitinib and hematoporphyrin by aptamer-modified fluorinated dendrimer for hypoxia alleviation and enhanced synergistic chemo-photodynamic therapy of NSCLC.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Dendrimers; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Hematoporphyrins; Humans; Hypoxia; Lung Neoplasms; Mutation; Photochemotherapy; Protein Kinase Inhibitors; Tumor Microenvironment | 2021 |
Killing effect of Ad5/F35-APE1 siRNA recombinant adenovirus in combination with hematoporphrphyrin derivative-mediated photodynamic therapy on human nonsmall cell lung cancer.
Topics: Adenoviridae; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; DNA-(Apurinic or Apyrimidinic Site) Lyase; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Genetic Therapy; Genetic Vectors; Hematoporphyrins; Humans; Inflammation; Lung Neoplasms; Photochemotherapy; Reactive Oxygen Species; RNA, Small Interfering | 2013 |
Knock down of the dual functional protein apurinic /apyrimidinic endonuclease 1 enhances the killing effect of hematoporphrphyrin derivative-mediated photodynamic therapy on non-small cell lung cancer cells in vitro and in a xenograft model.
Topics: Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; DNA Damage; DNA-(Apurinic or Apyrimidinic Site) Lyase; Female; Genetic Therapy; Hematoporphyrins; Humans; Lung Neoplasms; Mice; Photochemotherapy; Xenograft Model Antitumor Assays | 2010 |
Incorporation of photodynamic therapy as an induction modality in non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Hematoporphyrins; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Pneumonectomy; Postoperative Complications; Retrospective Studies; Survival Analysis; Treatment Outcome | 2006 |
Photodynamic therapy of non-small-cell carcinoma of the lung.
Topics: Carcinoma, Non-Small-Cell Lung; Debridement; Dihematoporphyrin Ether; Hematoporphyrins; Humans; Lung Neoplasms; Photochemotherapy | 1992 |
A pilot study of photodynamic therapy in patients with inoperable non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Dihematoporphyrin Ether; Female; Hematoporphyrins; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Photochemotherapy; Photosensitivity Disorders; Pilot Projects | 1992 |